Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.

294.66 1.43 +0.49%
Market cap
$112.5B
P/E
30.3×
Fwd P/E
24.1×
Dividend yield
1.19%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

47.95 41.40 37.64 32.36
P/S ratio
5.80 5.35 4.98 4.67
P/FCF ratio
33.36 31.36 27.53 25.68
P/Operating CF
91.79 62.68 216.55 95.75
P/B ratio
6.49 5.99 5.48 5.03
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
6.34 5.82 5.44 5.12
EV/EBITDA
32.16 24.02 22.16 19.57
EV/Operating CF
32.00 28.96 25.60 23.93
EV/FCF
36.48 34.11 30.10 28.12
Quick Ratio
0.94 1.04 1.04 1.08
Current Ratio
1.85 1.89 2.11 2.16
Net Debt/EBITDA
9.18 5.55 9.51 5.87
Debt/Assets
35.27% 33.15% 31.81% 31.17%
Debt/Equity
0.76 0.71 0.64 0.62
Asset Turnover
0.54 0.55 0.55 0.55
Operating CF/Net income
1.79 2.52 0.78 0.99
Capex/Depreciation
(0.07) (1.37) (0.55) (0.68)
Interest Coverage
— 5.80 6.32 11.77
Research and Development Expense of Revenue
6.77% 5.59% 6.86% 6.59%
Selling, General and Administrative Expense of Revenue
33.76% 31.06% 37.89% 33.83%
Intangible Assets out of Total Assets
0.53 0.52 0.53 0.53
Share Based Compensation of Revenue
1.02% 0.67% 1.45% 0.82%
Graham Net Nets
(0.08) (0.08) (0.08) (0.08)
Graham Number
99.41 105.86 108.57 117.02
Earnings Yield
2.09% 2.42% 2.66% 3.09%
Free Cash Flow Yield
3.00% 3.19% 3.63% 3.89%
Revenue per Share
15.84 18.76 15.72 17.18
Operating CF per Share
4.03 5.61 1.52 3.29
Capex per Share
(0.06) (1.13) (0.43) (0.53)
Free Cash Flow per Share
3.97 4.47 1.08 2.76
Cash per Share
8.74 10.73 7.74 9.06
Shareholders Equity per Share
56.97 58.66 60.01 62.55
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
56.97 58.66 60.01 62.55
Free Cash Flow
1,518.00 1,710.00 415.00 1,059.00
Working Capital
6,297.00 6,961.00 7,023.00 7,734.00
Capital Expenditures
(22.00) (433.00) (166.00) (202.00)
Net Current Asset Value
(11,561.00) (10,669.00) (9,974.00) (9,524.00)
EV/EBIT
42.18 29.88 27.58 23.89
Capex to Sales
0.00 0.06 0.03 0.03
Price to Operating Income
38.56 27.48 25.22 21.82
Other line items
Average Receivables
3,689.50 4,013.00 3,766.00 3,830.50
Average Payables
1,417.50 1,739.00 1,528.00 1,552.50
Average Inventory
5,331.00 5,042.00 5,262.00 5,405.00
Average Assets
45,445.00 45,407.50 46,148.50 47,130.50
Average Common Equity
20,967.00 21,527.00 21,954.50 22,589.50

Fold the line items

Columns are period end dates